Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Integra Flowable Wound Matrix
- Development stage
- Phase 4
- Lead developer
- Integra LifeSciences
- Modality
- Peptides, Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules, Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
Integra Flowable Wound Matrix (IFWM) is an injectable wound care product consisting of a lyophilized, micronized matrix of bovine tendon collagen and glycosaminoglycan (specifically chondroitin-6-sulfate). Developed by Integra LifeSciences, it is designed for the management of chronic and acute wounds with complex geometries, such as deep tunneled or cavity ulcers, where traditional sheet-form dermal substitutes cannot achieve adequate contact with the wound bed. The matrix acts as a three-dimensional scaffold that facilitates cellular infiltration, proliferation, and neo-vascularization, thereby promoting the regeneration of dermal tissue. It is frequently utilized in the treatment of diabetic foot ulcers, postsurgical wounds, and traumatic injuries, and has been explored for reconstructive applications such as nipple and nasal dorsum augmentation.
- Brand names
- Integra Flowable Wound Matrix
- Other names
- IFWMIntegra Flowable
Beyond the preview
Go deeper on Integra Flowable Wound Matrix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integra Flowable Wound Matrix.